Chlamydia trachomatis infection-associated risk of cervical cancer: A meta-analysis

Medicine (United States)

Volumn 95, Issue 13, 2016, Pages e3077-

  Zhu, Haiyan ^a   Shen, Zhaojun ^a   Luo, Hui ^a   Zhang, Wenwen ^a   Zhu, Xueqiong ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADENOCARCINOMA; ARTICLE; BLOOD ANALYSIS; CANCER RISK; CHLAMYDIASIS; CLINICAL EVALUATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOLOGY; HUMAN; META ANALYSIS; MIXED INFECTION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PUBLISHING; RETROSPECTIVE STUDY; RISK ASSESSMENT; SYSTEMATIC REVIEW; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; AGE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; RISK FACTOR; UTERINE CERVICAL NEOPLASMS;

AGE FACTORS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COINFECTION; FEMALE; HUMANS; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84962765780     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003077     Document Type: Article

References (51)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Schiffman M, Wentzensen N, Wacholder S, et al. Human papilloma virus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103:368-383.
3. Huh WK. Human papillomavirus infection: a concise review of natural history. Obstet Gynecol. 2009;114:139-143.
4. Stone KM, Zaidi A, Rosero-Bixby L, et al. Sexual behavior, sexually transmitted diseases, and risk of cervical cancer. Epidemiology. 1995;6:409-414.
5. Farivar TN, Johari P. Lack of association between Chlamydia trachomatis infection and cervical cancer-Taq Man realtime PCR assay findings. Asian Pac J Cancer Prev. 2012;13:3701-3704.
6. Tungsrithong N, Kasinpila C, Maneenin C, et al. Lack of significant effects of Chlamydia trachomatis infection on cervical cancer risk in a nested case-control study in North-East Thailand. Asian Pac J Cancer Prev. 2014;15:1497-1500.
7. Zereu M, Zettler CG, Cambruzzi E, et al. Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix. Gynecol Oncol. 2007;105:172-175.
8. Naucler P, Chen HC, Persson K, et al. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol. 2007;88:814-822.
9. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Dept of Epidemiology and Community Medicine, University of Ottawa: Ottawa, Canada. Error! Hyperlink reference not valid. [Accessed June 30, 2012]. 2011. 12.
10. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
11. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105-114.
12. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
13. Reesink-Peters N, Ossewaarde JM, Van Der Zee AG, et al. No association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia. Sex Transm Infect. 2001;77:101-102.
14. de Sanjose S, Munoz N, Bosch FX, et al. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer. 1994;56:358-363.
15. Castellsague X, Pawlita M, Roura E, et al. Prospective seroepide-miologic study on the role of human papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort. Int J Cancer. 2014;135:440-452.
16. Arnheim Dahlstrom L, Andersson K, Luostarinen T, et al. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:2541-2550.
17. Smith JS, Bosetti C, Munoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer. 2004;111:431-439.
18. da Silva Barros NK, Costa MC, Alves RR, et al. Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil. J Med Virol. 2012;84:1143-1150.
19. Golijow CD, Abba MC, Mouron SA, et al. Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol. 2005;96:181-186.
20. Hsieh CY, You SL, Kao CL, et al. Reproductive and infectious risk factors for invasive cervical cancer in Taiwan. Anticancer Res. 1999;19:4495-4500.
21. Ferrera A, Baay MF, Herbrink P, et al. A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras. Int J Cancer. 1997;73:781-785.
22. Jha PK, Beral V, Peto J, et al. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet. 1993;341:1116-1118.
23. Schmauz R, Okong P, de Villiers EM, et al. Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer. 1989;43:805-809.
24. Kalimo K, Terho P, Honkonen E, et al. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia. Br J Obstet Gynaecol. 1981;88: 1130-1134.
25. Hare MJ, Taylor-Robinson D, Cooper P. Evidence for an association between Chlamydia trachomatis and cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1982;89:489-492.
26. Dong YZ, Sasagawa T, Fang SY, et al. Human papillomavirus, Chlamydia trachomatis, and other risk factors associated with cervical cancer in china. Int J Clin Oncol. 1998;3:81-87.
27. Kwasniewska A, Korobowicz E, Zdunek M, et al. Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples. Eur J Gynaecol Oncol. 2009;30:65-70.
28. Bebear C, de Barbeyrac B. Genital Chlamydia trachomatis infections. Clin Microbiol Infect. 2009;15:4-10.
29. Ohman H, Tiitinen A, Halttunen M, et al. Cytokine polymorphisms and severity of tubal damage in women with Chlamydia-associated infertility. J Infect Dis. 2009;199:1353-1359.
30. Paavonen J, Karunakaran KP, Noguchi Y, et al. Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer. Am J Obstet Gynecol. 2003;189:1287-1292.
31. Simonetti AC, Melo JH, de Souza PR, et al. Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect. 2009;11:435-442.
32. Verteramo R, Pierangeli A, Mancini E, et al. Human papilloma-viruses and genital co-infections in gynaecological outpatients. BMC Infect Dis. 2009;9:16.
33. Grieshaber SS, Grieshaber NA, Miller N, et al. Chlamydia tracho-matis causes centrosomal defects resulting in chromosomal segregation abnormalities. Traffic. 2006;7:940-949.
34. Johnson KA, Tan M, Sütterlin C. Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway. Cell Microbiol. 2009;11:1064-1073.
35. Knowlton AE, Brown HM, Richards TS, et al. Chlamydia trachoma-tis infection causes mitotic spindle pole defects independently from its effects on centrosome amplification. Traffic. 2011;12:854-866.
36. Sun HS, Wilde A, Harrison RE. Chlamydia trachomatis inclusions induce asymmetric cleavage furrow formation and ingression failure in host cells. Mol Cell Biol. 2011;31:5011-5022.
37. Prozialeck WC, Fay MJ, Lamar PC, et al. Chlamydia trachomatis disrupts N-cadherin-dependent cell-cell junctions and sequesters beta-catenin in human cervical epithelial cells. Infect Immun. 2002;70:2605-2613.
38. Discacciati MG, Gimenes F, Pennacchi PC, et al. MMP-9/RECK imbalance: a mechanism associated with high-grade cervical lesions and genital infection by human papillomavirus and Chlamydia trachomatis. Cancer Epidemiol Biomarkers Prev. 2015;24:1539-1547.
39. Knowlton AE, Fowler LJ, Patel RK, et al. Chlamydia induces anchorage independence in 3T3 cells and detrimental cytological defects in an infection model. PLoS One. 2013;8:e54022.
40. Safaeian M, Quint K, Schiffman M, et al. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst. 2010;102:1794-1804.
41. Kim S, Arduino JM, Roberts CC, et al. Incidence and predictors of human papillomavirus-6,-11,-16, and-18 infection in young norwegian women. Sex Transm Dis. 2011;38:587-597.
42. Jensen KE, Thomsen LT, Schmiedel S, et al. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study. Sex Transm Infect. 2014;90:550-555.
43. Silins I, Ryd W, Strand A, et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer. 2005;116:110-115.
44. Insinga RP, Perez G, Wheeler CM, et al. Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiol Biomarkers Prev. 2010;19:1585-1594.
45. Horvath CA, Boulet GA, Renoux VM, et al. Mechanisms of cell entry by human papillomaviruses: an overview. Virol J. 2010;7:11.
46. Paba P, Bonifacio D, Di Bonito L, et al. Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology. 2008;51:230-234.
47. Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007;107: S2-S5.
48. Koskela P, Anttila T, Bjorge T, et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer. 2000;85:35-39.
49. Littman AJ, White E, Jackson LA, et al. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:1624-1630.
50. Laurila AL, Anttila T, Laara E, et al. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer. 1997;74:31-34.
51. Quint KD, de Koning MN, Geraets DT, et al. Comprehensive analysis of human papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma. Gynecol Oncol. 2009;114:390-394.